会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • Nanoparticle-Based Gene Delivery Systems
    • 基于纳米粒子的基因递送系统
    • US20110229966A1
    • 2011-09-22
    • US12809996
    • 2010-03-18
    • Min Su HanKangseok LeeDong-Eun Kim
    • Min Su HanKangseok LeeDong-Eun Kim
    • C12N5/00
    • C12N15/113A61K31/7105A61K31/713A61K47/6923C12N15/111C12N15/87C12N15/89C12N2310/11C12N2310/127C12N2310/14C12N2310/351C12N2310/51C12N2310/531C12N2320/32Y10S977/773
    • The present invention provides a gene delivery system containing nanoparticles. In more detail, the present invention provides a gene delivery system containing (a) a nanomaterial; (b) an oligonucleotide as an universal binding partner covalently linked to the surface of the nanomaterial; and (c) a cargo comprising (i) a complementary oligonucleotide containing a nucleotide sequence complementary to the universal binding partner as a binding counter-partner, and (ii) an inhibitory molecule having a nucleotide sequence complementary to a target gene of interest to be inhibited or an inducible molecule having a nucleotide sequence of a target gene of interest to be expressed. The present invention is a gene delivery system capable of feasibly deliver aptamer, siRNA, shRNA, miRNA, ribozyme, DNAzyme, PNA or gene as well as antisense oligonucleotide into the cells. In addition, the present invention is more efficient than the commercially available gene transfer reagent in respect to the degree of knockdown of target protein expression.
    • 本发明提供含有纳米颗粒的基因递送系统。 更详细地,本发明提供了一种基因递送系统,其包含(a)纳米材料; (b)与纳米材料的表面共价连接的通用结合配偶体的寡核苷酸; (c)货物,其包含(i)含有与通用结合配偶体互补的核苷酸序列作为结合对配体的互补寡核苷酸,和(ii)具有与目的靶基因互补的核苷酸序列的抑制性分子, 或具有待表达的靶基因的核苷酸序列的诱导型分子。 本发明是能够将适体,siRNA,shRNA,miRNA,核酶,DNA酶,PNA或基因以及反义寡核苷酸可行地递送到细胞中的基因递送系统。 此外,与靶蛋白质表达的敲低程度相比,本发明比市售的基因转移试剂更有效。
    • 4. 发明授权
    • Developing unit and image forming apparatus having the same
    • 显影单元及其成像装置
    • US08600261B2
    • 2013-12-03
    • US12632205
    • 2009-12-07
    • Min Su Han
    • Min Su Han
    • G03G15/08
    • G03G21/1832G03G15/0882G03G21/181
    • Disclosed are a developing unit and an image forming apparatus having the same. The developing unit includes a partition frame provided separately from the housing of the developing unit. The partition frame is supported within the housing of the developing unit in such a manner to define a path of movement of developer within the housing through an opening formed in the partition frame. A removable sealing member is detachably arranged on the partition frame to prevent developer leakage during storage or transporting of the developing unit. The installation of the removable sealing member is made easier by the partition frame provided separately from the housing.
    • 公开了一种显影单元和具有该显影单元的图像形成装置。 显影单元包括与显影单元的壳体分开设置的分隔框架。 分隔框架以这样的方式被支撑在显影单元的壳体内,即通过形成在分隔框架中的开口限定显影剂在壳体内移动的路径。 可移除的密封构件可拆卸地布置在分隔框架上,以防止在显影单元的储存或运输期间显影剂泄漏。 通过与壳体分开设置的分隔框架,更容易地安装可拆卸的密封构件。
    • 9. 发明申请
    • REAL-TIME COLORIMETRIC SCREENING INHIBITORS OF ENDONUCLEASE WITH GOLD NANOPARTICLE SUBSTRATE
    • 具有金纳米晶基质的内切酶的实时彩色荧光筛选抑制剂
    • US20090155785A1
    • 2009-06-18
    • US12020506
    • 2008-01-25
    • Chad A. MirkinXiaoyang XuMin Su Han
    • Chad A. MirkinXiaoyang XuMin Su Han
    • C12Q1/68
    • G01N33/553B82Y5/00C12Q1/34G01N33/587
    • The invention provides methods for screening a compound for its effect on endonuclease activity. The methods comprise providing a compound to be screened utilizing a gold nanoparticle aggregate as the substrate for the endonuclease. The gold nanoparticle aggregate is formed by the hybridization of oligonucleotides attached to the nanoparticles, with or without the presence of a third linker oligonucleotide. The hybridized oligonucleotide duplex serves as a substrate for the endonuclease. A detectable change is brought about in the presence of the endonuclease activity. A decrease in the detectable change reflects the reduced levels of endonuclease activities as a result of the effects of endonuclease inhibitors. The present invention also provides kits for screening an endonuclease inhibitor.
    • 本发明提供了筛选化合物对其对核酸内切酶活性的影响的方法。 所述方法包括使用金纳米颗粒聚集体作为内切核酸酶的底物提供待筛选的化合物。 金纳米颗粒聚集体通过与或不与第三接头寡核苷酸的存在连接到纳米颗粒上的寡核苷酸的杂交形成。 杂交的寡核苷酸双链体用作内切核酸酶的底物。 在存在核酸内切酶活性的情况下可以发现可检测的变化。 可检测变化的降低反映了由于内切核酸酶抑制剂的作用而导致的内切核酸酶活性的降低。 本发明还提供了用于筛选内切核酸酶抑制剂的试剂盒。